• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Novartis

Novartis

Novartis AG ADR NVS 3 Star

Last Price$93.90Day Change (%)-0.95%
Open Price$93.84Day Change ($)-0.90
Day Range93.64–94.1752-Week Range72.77–95.50

As of Fri 09/19/2014 04:31 PM EST | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Novartis' new heart failure medicine LCZ696 cut cardiovascular deaths by 20% vs. ACE-inhibitor in landmark PARADIGM-HF trial

    Novartis' new heart failure medicine LCZ696 cut cardiovascular deaths by 20% vs. ACE-inhibitor in landmark PARADIGM-HF trial

  2. Blockbusters Differentiate Novartis

    The company's diverse operating divisions and robust pipeline should lead to steady growth.

  3. Novartis up, Iliad drops: European movers

    Novartis up, Iliad drops: European movers

  4. UPDATE: Novartis climbs, Iliad drops: European movers

    UPDATE: Novartis climbs, Iliad drops: European movers

  5. EUROPE MARKETS: Novartis Up, Iliad Drops: European Movers

    EUROPE MARKETS: Novartis Up, Iliad Drops: European Movers

  6. EUROPE MARKETS: Novartis Climbs, Iliad Drops: European Movers

    EUROPE MARKETS: Novartis Climbs, Iliad Drops: European Movers

  7. UPDATE: These 10 boring stocks will beat your portfolio

    UPDATE: These 10 boring stocks will beat your portfolio

  8. Research and Markets: Global Multiple Sclerosis Drugs Market 2014-2018 Featuring Bayer, Biogen Idec, Merck Serono, Novartis & Teva Pharmaceutical

    Research and Markets: Global Multiple Sclerosis Drugs Market 2014-2018 Featuring Bayer, Biogen Idec, Merck Serono, Novartis & Teva Pharmaceutical

  9. The Ultimate Stock-Pickers’ Top 10 Dividend Stocks

    Top managers continue to focus on higher-quality dividend-paying stocks in a fully valued market.

  10. Research and Markets: Global Moderate Psoriasis Therapeutics Pipeline Report 2014 - 17 Companies & 23 Drug Profiles

    Research and Markets: Global Moderate Psoriasis Therapeutics Pipeline Report 2014 - 17 Companies & 23 Drug Profiles

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.